• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More or Call (407) 374-6986

Wednesday 12/12/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

neurological

  • 11:15 AM

    THC prodrugs including VBX-100 designed to deliver cannabinoids for targeted therapeutic effects without psychoactivity LOS ANGELES, March 28, 2018 (GLOBE NEWSWIRE) — Vitality Biopharma, Inc. (OTCQB:VBIO) (“Vitality” or the “Company”) a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced the filing of its cannabosides intellectual property (Publ. No. WO2017053574 A1) in all major pharmaceutical markets worldwide. After initial submission through the Patent Cooperation

    Read more
  • 11:42 AM

    Approval of cannaboside pharmaceutical research included review by FDA and California Research Advisory Panel LOS ANGELES, CA– VBIO, (Marketwired – Dec 21, 2016) – Vitality Biopharma, Inc. (OTCQB: VBIO) (“Vitality Biopharma,” “Vitality,” or the “Company”), a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced that it has received approval from both the U.S. Drug Enforcement Agency (DEA) and the State of

    Read more
  • 4:29 PM

    NEWTOWN, PENNSYLVANIA– HSDT, (Marketwired – Jun 6, 2016) – Helius Medical Technologies, Inc. (TSX:HSM)(OTCQB:HSDT) (“Helius” or the “Company”) a medical technology company focused on the treatment of neurological symptoms caused by disease or trauma, is pleased to announce that it received proceeds of CDN $1,825,600 (approximately US$1,409,947) from the exercise of certain warrants issued in 2014, all of which was received after the Company’s fiscal year end on March 31, 2016. The warrants expired on May 30, 2016 and were

    Read more
  • 7:35 PM

    Amerigo Energy http://www.Publicwire.com Up almost $2 million from this point in 2013. (PublicWire.com Press Release) — HENDERSON, Nev., Feb 10, 2014 (GLOBE NEWSWIRE via COMTEX) — via PRWEB – Quest Solution, Inc. “Quest”, a wholly owned subsidiary of Amerigo Energy, Inc. “The Company” (OTCBB: AGOE), discussed results so far for 2014. Kurt Thomet, President of Quest Solution, Inc. stated “Our 2014 numbers have started the year very strong. So far we are having the best performance in Company history with

    Read more
Public Wire Banner